Genomic Markers + Active Surveillance May 4, 2017 by Prostatepedia Leave a comment Dr. Gerald L. Andriole talks about how we can use genomic markers to determine which patients can safely chose active surveillance. Not a member? Join us. Share this:TwitterFacebookLike this:Like Loading... Related Author: Prostatepedia Conversations about prostate cancer.